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Abstract.  Xenopus  laevis oocytes have been used to 
determine the intracellular localization of components 
of Ro ribonucleoprotein particles (Ro RNPs) and to 
study the assembly of these RNA-protein complexes. 
Microinjection of the protein components of human Ro 
RNPs, i.e., La, Ro60,  and Ro52, in X.  laevis oocytes 
showed that all three proteins are able to enter the nu- 
cleus, albeit with different efficiencies.  In contrast, the 
RNA components of human Ro RNPs (the Y RNAs) 
accumulate in the X.  laevis cytoplasm upon injection. 
Localization studies performed at low temperatures in- 
dicated that both nuclear import of Ro RNP proteins 
and nuclear export of Y RNAs are mediated by active 
transport mechanisms. 
Immunoprecipitation experiments using monospecific 
anti-La and anti-Ro60 antibodies showed that the X. 
laevis La and Ro60 homologues were cross-reactive 
with the respective antibodies and that both X.  laevis 
proteins were able to interact with human Y1  RNA. 
Further analyses indicated that: (a)  association of X. 
laevis La and Ro60 with Y RNAs most likely takes 
place in the nucleus; (b) once formed, Ro RNPs are 
rapidly exported out of the nucleus; and (c) the as- 
sociation with La is lost during or shortly after nu- 
clear export. 
T 
IlE Ro/SS-A and La/SS-B antigens are common targets 
of autoimmune responses  occurring  in a number  of 
rheumatic disorders, of which systemic lupus erythe- 
matosus  and  Sj6gren's syndrome are the most prominent 
(reviewed in Tan, 1989). Antibodies against these antigens 
have been of great help in the characterization of these au- 
toantigens and they also have some clinical interest in diag- 
nosing different rheumatic diseases (reviewed in Slobbe et 
al., 1991a). The Ro/SS-A antigen consists of  a set of  ribonu- 
cleoprotein  particles  (Ro RNPs).~ Ro RNPs consist of an 
RNA molecule, complexed with several proteins. The RNAs 
are transcribed by RNA polymerase III and, in humans, vary 
in length from 84 to 112 nucleotides (Hendrick et al., 1981). 
They are referred to as hY1, hY3, hY4, and hY5 RNA (hY2 
RNA is a truncated version of hY1 RNA). Their sequences 
have been determined (Kato et al., 1982; Wolin and Steitz, 
1983; O'Brien and Harley, 1990) and the predicted second- 
ary structures are characterized by base pairing of the highly 
conserved 5' and 3' termini (reviewed by van Venrooij et al., 
1993). The number of Y RNAs differs among species, vary- 
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1. Abbreviations  used in this paper:  NLS, nuclear localization signal; Ro 
RNP, Ro ribonucleoprotein particle. 
ing from two in duck and mouse to four in several other 
mammals  (Hendrick  et al.,  1981; Mamula et al.,  1989a; 
Pruijn et al., 1993). In human tissues also a difference in the 
distribution of the four Y RNAs has been detected: in red 
blood  cells  only hY1  and hY4 RNA (Rader et al.,  1989; 
O'Brien and Harley, 1990) and in human platelets only hY3 
and hY4 RNA (Itoh and Reichlin,  1991) could be detected, 
while other human cells contain all four Y RNAs. 
The protein part of a Ro RNP consists of at least three 
different proteins: the La protein (La) and the 52- and 60-kD 
Ro proteins (Ro52 and Ro60, respectively). One of the func- 
tions proposed for La is a role in the correct termination of 
transcription  by RNA polymerase III (Gottlieb and Steitz, 
1989a, b).  La binds transiently to all RNA polymerase III 
transcripts, but is believed to bind to Y RNAs more stably, 
because Y RNAs don't lose their 3' U-tail which is the pri- 
mary binding site for the La protein (Stefano, 1984; Mathews 
and Francoeur,  1984; Pruijn et al., 1991). For the Ro pro- 
teins different variants have been found in different cell types. 
While most human cells contain Ro60 and Ro52, red blood 
cells contain Ro proteins of  60 and 54 kD which are antigeni- 
cally different from, but related to Ro60 and Ro52, respec- 
tively (Rader et al.,  1989). Moreover, in human platelets 
only a 52-kD Ro protein can be detected that is also antigeni- 
cally different from Ro52 (Itoh and Reichlin,  1991). The 
binding site for Ro60 is the terminal part of the conserved 
stem  structure  of the  Y  RNAs (Wolin and Steitz,  1984; 
©  The Rockefeller  University  Press, 0021-9525/94/06/981/8  $2.00 
The Journal of Cell Biology, Volume 125, Number 5, June 1994 981-988  981 Pruijn et al., 1991). Ro52 does not seem to bind directly to 
Y RNA, but most likely associates with the particle via pro- 
tein-protein interactions with Re60 (Slobbe et al.,  1992). 
However, direct evidence for the association of  Ro52 with Re 
RNPs is still lacking and is complicated by the fact that some 
anti-Re52 antibodies have been reported to cross-react with 
Re60 (Itoh et al.,  1992). 
Although a number of functions for Re RNPs have been 
proposed (reviewed in Pruijn et al., 1990),  the actual func- 
tion of these particles is still unknown. Also their intracellu- 
lar localization is not clear yet. This subject has been ad- 
dressed in several studies, but the results are controversial. 
By immunofluorescence Re protein components were de- 
tected in only the nucleus (Harmon et al.,  1984;  Lopez- 
Robles et al., 1986; Xia et al., 1987; Mamula et al., 1989a), 
in both nucleus and cytoplasm (Ben-Chetrit et al.,  1988; 
Slobbe et al., 1991b) or merely in the cytoplasm (Alspaugh 
and Maddison, 1979;  Hendrick et al.,  1981; Bachmarm et 
al.,  1986).  We  studied the  intracellular localization and 
transport of Re RNPs by microinjection of  the different com- 
ponents  into Xenopus laevis oocytes.  This  approach  has 
proven to be very successful in studying transport of other 
RNPs,  in particular U1  snRNP  (reviewed in Nigg et al., 
1991). 
In this study in vitro translated La, Ro52, and Re60 were 
injected into the oocyte cytoplasm to elucidate their trans- 
port and localization. The Y RNAs, on the contrary, were 
injected into the nucleus of oocytes. The association of hY1 
RNA with X./aev/s La and Re60 was examined by immune- 
precipitation studies. Our results suggest a model in which 
the Re and La proteins after their synthesis are transported 
to the nucleus, where they associate with the newly synthe- 
sized Y RNAs. The assembled Re RNP particles are then 
rapidly exported to the cytoplasm. 
Materials and Methods 
In vitro Transcription~Translation 
The transcription vectors for hY RNAs were derived from pHY1,  pHY3, 
pHY4, and pHY5 (Pruijn et al.,  1991; Peek et al.,  1993).  By PCR a T7 
RNA polymerase promoter was inserted at a position that allowed wild-type 
5'-end formation during transcription and a DraI site was created at a posi- 
tion corresponding to the Tend of the respective hY RNA. The PCR prod- 
ucts were cloned into pUC18. The U1 snRNA clone in pUC19 has been de- 
scribed by Surowy et al.  (1989).  After linearization with DraI (hY1) and 
Ddel (U1) and transcription with T7 RNA polymerase, RNAs correspond- 
ing to the wild-type sequences were obtained. The U1 clone was transcribed 
in the presence of m7G(5')ppp(5~G  cap. 0.5 pg of linearized template DNA 
was transcribed in 10 ~1 buffer, containing 40 mM Tris-HC1, pH 7.9, 6 mM 
MgC12, 2 mM spermidine, 10 mM NaC1,  10 mM dithiothreitol, 0.1 mg/ml 
BSA,  1 mM NTPs, 2  U RNasin,  1 mM m7G(5~ppp(5')G  (in case of U1 
RNA), and 20 tzC~ [c~32P]UTP with 10 U of T'/RNA polymerase. Unin- 
corporated nucleotides were removed by gel filtration and proteins were re- 
moved by phenol-chloroform (1:1) extraction. 
The eDNA clones for La and Re60, used for in vitro transcription/trans- 
lation, have been previously described by Pruijn et al. 0991).  The Ro52 
eDNA clone used is identical to the Ro52  eDNA clone described by Itoh 
and co-workers (1991) and was isolated from a human placental eDNA li- 
brary and subcloned into pGEM-3Zf(+) (Bozic et al., 1993).  In vitro tran- 
scription/translation was carried out as described by Scherly et al. (1989). 
Oocyte Injection 
Oocytes were released from the ovary by treatment with eoUagenase B (2.5 
mg/ml) in Barth medium without Ca  2+. For protein studies 40 ni of the in 
vitro translation mixture was injected into the cytoplasm of fully grown oo- 
cytes and subsequently incubated in Barth medium supplemented with cy- 
eloheximide at a concentration of 100 pg/rnl. After 18 h the oocyte~ were 
manually dissected in J buffer (20 mM Tris-HC1,  pH 7.5, 70 mM NI-hCI, 
7 m/vl MgCl2, 0.1 mM EDTA, 2.5 mM dithiothreitol, 10% glycerol). The 
nuclear fraction was precipitated immediately in ethanol, whereas the "to- 
tal" and cytoplasmic fractions were first homogenized in TNI.~E (10 mM 
Tris-HC1,  pH 8.0, 150 mM NaC1,  1 mM EDTA). After removal of part of 
the yolk and insoluble components by centrifugation, proteins were precipi- 
tated by adding 5 vol of acetone. Pellets were resnspended in SDS sample 
buffer and  portions of four oocyte equivalents were  analyzed by  10% 
SDS-PAGE. 
For RNA injections, oocytes were first centrifuged (600 g, 20 min, room 
temperature) to visualize the nucleus. 25 nl of the in vitro transcribed RNA 
was injected into the nucleus of oocytes. After incubation and dissection 
of the oocytes the fractions were homogenized in 50 mM Tris-HC1, pH 7.5, 
5 mM EDTA, 1.5% SDS, 300 mM NaC1,  1.5 mg/ml proteinase K, and in- 
cubated at 56°C for 30 rain. Proteins were extracted once with phenol/chlo- 
rofurm (1:1) and RNA was precipitated by adding 4 vol of ethanol. RNA 
of one oocyte equivalent was analyzed on a 10% denaturing polyaerylamide 
gel. For immtmoprecipitation oocytes were homogenized in TNIsoE. 
The X. laevis U1 RNA gene used for injection is described by Zeller et 
al.  (1984).  The hY RNA genes are located on a genomie DNA fragment 
described by Wolin and Steitz (1983). The hY1 and bY3 genes were first sub- 
cloned by ligating the EcoRI-SalI fragment (hY1) and EcoRI-BamI-lI frag- 
ment (hY3) into pGEM-3Zf(+). The DNA (1 mg/ml) was mixed with an 
equal volume of [~-32p]UTP (10 mCi/ml) and injected (25 nl) into the oo- 
cyte nuclei. After 40 h, RNA was extracted from the oocytes and analyzed 
on polyaerylamide gels. Gel-purified RNA (Mattaj and Zeller, 1983) was 
dissolved in water and re-injected into the oocyte nucleus and analyzed as 
described. 
Antisera 
The anti-La, anti-Re60, and anti-Sm sera were from autoimmune patients. 
The anti-La and anti-Re60 antibodies were affinity purified using bacteri- 
ally expressed La and Re60 (Slobbe et al.,  1992).  Their monospecifieity 
was confirmed by Western blotting and by immunoprecipitation of in vitro 
translated proteins. The specificity of the anti-Sm serum was determined 
by Western blotting, counter-immunoelectrophoresis, and RNA precipi- 
tation. 
Immunoprecipitation 
Antisera were coupled to protein A-agarose by head over head rotation at 
room temperature for 1 h in IPP~00 (10 mM Tris-HC1,  pH 8.0, 500 mM 
NaC1, 0.1% NP-40). For each precipitation 50 tzl of aflinity-purifled  anti-La 
or anti-Re60 or 2 pl of anti-Sin or normal human serum were used. Im- 
munoprecipitations were carried out in IPPtso (10 mM Tris-HC1,  pH 8.0, 
150 mM NaC1, 0.1% NP-40) fur 2 h at 4°C. Immunoprecipitation with oo- 
cyte extracts was performed with three oocyte equivalents. The RNA was 
extracted and analyzed as described in the oocyte injection section. 
For immunoprecipitation of endogenous proteins, oocytes were labeled 
in Barth medium with 0.5 mCi [3SS]methionine.  After 40 h the oocytes 
were homogenized in  Sl00-buffer (25  mM Tris-HC1,  pH  7.4,  0.1  mM 
EDTA,  0.25  mM dithiothreitol, 0.5  mM phenylmethylsulfunyl fluoride, 
0.I M KCI, 0.01% NP-40,  20% glycerol), centrifuged to remove insoluble 
components and yolk, and then used fur immunoprecipitation. The precipi- 
tated proteins were resuspended in SDS sample buffer and analyzed by 10% 
SDS-PAGE. 
Results 
Nuclear Import of Human La, Ro52, and Re60 in 
X. laevis Oocytes 
Because immunofluorescence led to controversial localiza- 
tion data, especially in the case of the Re proteins, the intra- 
cellular localization of the Re RNP proteins was studied by 
an alternative approach.  In vitro translated La, Re60, and 
Ro52 proteins were injected into the cytoplasm of X. laevis 
oocytes. After an overnight incubation the intracellular dis- 
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vitro translated La (a), Ro60 (b), and Ro52 (c) were injected into 
the cytoplasm of X. /aev/s oocytes. After incubation at room tem- 
perature (RT) Oanes 3-5) or 0°C 0aries 6-8) for 18 h, ooeytes (T) 
were  dissected  into  cytoplasmic  (C)  and nuclear  (N)  fractions 
which were analyzed by 10% SDS-PAGE. (Lanes 1 ) Protein mo- 
lecular weight markers. (Lanes 2) In vitro translation products used 
for injection (i). The positions of  the full-length La, Ro60 and Ro52 
polypeptides in the gel are indicated. The apparent difference in 
migration between nuclear and cytoplasmic La protein is due to the 
presence of some remaining yolk protein in the cytoplasmic frac- 
tion. When nuclear La is analyzed in combination with cytoplasmic 
La (lane T), i.e., in the presence of cytoplasmic material, it also 
migrates like cytoplasmic La. Note that migration of La in the nu- 
clear fraction is identical to that of the in vitro translation product, 
which was used for injection. 
tribution was determined by dissection of the oocytes and 
analysis of the cytoplasmic and nuclear fractions. 
Injected  35S-labeled  recombinant  proteins,  obtained  by 
translation  in  a  wheat  germ  extract,  became  distributed 
among nucleus and cytoplasm after an overnight incubation. 
The La protein showed a strong nuclear accumulation leav- 
ing only a minor part in the cytoplasm (Fig. 1 a, lanes 3-5). 
Also a substantial amount of Ro60 had entered the nucleus 
(Fig. 1 b, lanes 3-5), although the efficiency  of nuclear entry 
appeared to be somewhat lower than that for La. In case of 
Ro52 most of the protein remained in the cytoplasm,  al- 
though detectable amounts were reproducibly imported into 
the nucleus (Fig. 1 c, lanes 3-5). When La, Ro52, and Ro60 
were injected into the nucleus of oocytes instead of into the 
cytoplasm the same distribution between cytoplasm and nu- 
cleus after an overnight incubation was obtained (data not 
shown),  suggesting  that  the  observed distributions  reflect 
equilibrium situations. 
In the La translation mixture (Fig.  1 a, lane 2) the full- 
length protein is accompanied by a prominent smaller poly- 
peptide. This represents a characteristic degradation product 
of the La protein (Habets et al., 1983; Chan and Tan, 1987), 
caused by the presence of a  so-called PEST region in the 
middle of the protein (Chart et ai.,  1989a), which is known 
to  be  very  susceptible  to  proteolytic  degradation.  This 
degradation product represents the NH2-terminal half of the 
La protein, because only this part contains methionines and 
thus is the part of the protein that will be radioactively la- 
beled during  in  vitro translation by  psS]methionine.  The 
observation that this truncated variant of La completely re- 
mained in the cytoplasm (Fig.  1 a, lanes 3-5) strongly sug- 
gests that transport of the full-length La protein to the nu- 
cleus is not caused by diffusion. 
To investigate the mechanism of nuclear import of all three 
proteins the oocytes were, after injection, incubated at 0°C 
instead of at room temperature. This approach allows us to 
distinguish between diffusion and active transport because 
incubation  at  0°C  severely  reduces  the  rate  of  energy- 
dependent  transport  while  diffusion  is  hardly  influenced 
(Newmeyer et al.,  1986; Breeuwer et al.,  1990). As shown 
in Fig.  1, a-c, transport to the nucleus of La, Ro60, as well 
as  Ro52  was  drastically  reduced  when  oocytes were  in- 
cubated at 0°C (lanes 6--8) in comparison with incubations 
at room temperature (lanes 3-5).  Furthermore, this effect 
appeared to be reversible: oocytes, that were first incubated 
at 0°C for 18 h  and subsequently at room temperature for 
24 h, displayed protein distributions similar to oocytes that 
had  been  incubated  at  room  temperature  only  (data  not 
shown). 
As a control, the U1A protein which previously has been 
shown to be actively transported to the nucleus (Kambach 
et al.,  1992),  was included in these types of experiments. 
Nuclear import of the  UIA protein was  also  severely in- 
hibited at 0°C and restored when oocytes were subsequently 
incubated at room temperature (data not shown). From these 
results we conclude that the La, Ro52, and Ro60 proteins are 
transported to the nucleus via an active process. 
Nuclear Export of Y RNA in Xenopus laevis Oocytes 
Having observed active nuclear import of the three different 
Ro RNP proteins, the localization of the RNA components 
of Ro RNPs in X.  laevis oocytes was studied. For this pur- 
pose, in vitro transcribed hY1, hY3, hY4, and hY5 RNA were 
injected into the nucleus of  oocytes, i.e., in the cellular com- 
partment where they are synthesized, and the distribution 
of the  RNAs  4  and  18  h  after injection was  studied.  In 
vitro transcribed U1  snRNA was co-injected as a  control. 
Simons et al. lntraceUular  Localization of Ro RNP Components  983 Figure 2. Nuclear export of hY RNAs. (a) In vitro transcribed hY1, 
hY3, bY4, hYS, and U1 RNA were co-injected into oocyte nuclei. 
RNA was extracted from total oocytes (T), cytoplasmic (C), and 
nuclear (N) fractions immediately (lanes 1-3), 4 h (lanes 4-6), 
18 h (lanes 7-9), and 42 h (lanes 10-12) after injection and ana- 
lyzed on a denaturing polyacrylamide gel. (b) In vivo transcribed 
bY3 RNA and U1 RNA were gel purified and re-injected into the 
oocyte nucleus. Immediately (lane 1), 4 h (lanes 2-4), and 24 h 
(lanes 5-7) after injection, oocytes were dissected and the extracted 
RNAs analyzed on a denaturing polyacrylamide gel. (c) In vitro 
transcribed bY1 RNA and U1 RNA were co-injected into the oocyte 
nucleus  and  subsequently incubated at  room temperature  (RT) 
(lanes 2-4) or 0°C (lanes 5-7) for 18 h. Thereafter RNA was ex- 
tracted from the fractions and analyzed. (Lane 1 ) RNA extracted 
from oocytes immediately after injection. 
Fig. 2 a shows that, upon injection into the nucleus, hY1, hY3, 
and hY4 RNA gradually moved to the cytoplasm. The distri- 
bution ofhY5 RNA was not clear since it was not stable upon 
injection into the oocyte. After '~8 h nuclear export of hY1 
RNA was completed (data not shown). The control RNA, U1 
snRNA, was, as expected, first transported to the cytoplasm 
before returning to the nucleus (Fig. 2 a) (see Nigg et al., 
1991), 
In vitro produced hY RNAs are structurally identical to hY 
RNAs isolated from human cells, except for the 3' uridine 
stretch which is 4-nucleotides long rather than 2 or 3. Appar- 
ently, these in vitro produced molecules are quite stable in 
oocytes. However, the possibility that the behavior of an in- 
jected in vitro produced hY RNA is different from that of an 
endogenously transcribed equivalent can not be excluded. 
Therefore, hY  RNA  genes  (encoding hY1  and hY3  RNA) 
were injected in  the oocyte nucleus together with  [ot-32p] 
UTP. A X.  /aev/s U1 RNA gene was injected as a control. 
Both hY3  RNA  and  U1  RNA  were transcribed efficiently 
in oocytes, in contrast to hY1 RNA which was transcribed 
very poorly (data not shown). Therefore, the endogenously 
transcribed hY3 and U1 RNAs were isolated and re-injected. 
Fig. 2 b shows that the distribution of these RNAs was simi- 
lar to that of the in vitro transcribed RNAs (Fig. 2, compare 
a with b). Also in this case the hY RNA was predominantly 
located in the cytoplasm while U1 RNA localized primarily 
in the nucleus 24 h after injection. The distribution of in vivo 
transcribed hY3 RNA was also studied directly after injec- 
tion of the hY3 gene (and the U1 gene as a control) into the 
oocyte nucleus along with radioactive label and analysis of 
the  cytoplasmic  and  nuclear  localization  of  transcribed 
RNAs after a relatively long period of  time (40 h). Since both 
Y RNAs and U RNAs are rather stable in X./aev/s oocytes, 
one would expect a distribution that strongly resembles the 
real distribution of in vivo transcripts.  Indeed, also in this 
experiment hY3 RNA was found to be primarily cytoplasmic 
in contrast to U1 RNA, which was, as expected, mainly nu- 
clear (data not shown).  We conclude that the intracellular 
transport of the in vitro transcribed RNAs is indistinguish- 
able from that of the in vivo transcribed RNAs. 
To investigate whether transport of hY RNA to the cyto- 
plasm  was  an energy-dependent process,  injected oocytes 
were incubated at 0°C. Virtually no export to the cytoplasm 
of hY1 RNA nor of U1  RNA could be observed (Fig. 2  c, 
compare lanes 2-4 with 5-7),  strongly suggesting that nu- 
clear export of hY1 RNA to the cytoplasm is an active pro- 
cess. We conclude that hY RNA, after synthesis in the nu- 
cleus,  is  actively transported  to  and  accumulates  in  the 
cytoplasm. 
Formation of  Ro RNPs in Xenopus laevis Oocytes 
The observations that the Y RNAs accumulate in the oocyte 
cytoplasm and that the Ro proteins at least in part move to 
the nucleus, prompted us to investigate whether the injected 
bY1 RNA associates with X.  /aev/s proteins leading to the 
formation of a ribonucleoprotein particle. We hypothesized 
that such proteins would be homologous to the human Ro 
and La proteins. Recently, the presence of two variants of  the 
La protein as well as a Ro60 homologue in X.  laevis have 
been reported and cDNAs encoding these proteins have been 
cloned (Scherly et al., 1993; O'Brien et al., 1993). To inves- 
tigate the association of hY1 RNA with X.  laevis Ro60 and 
La proteins, affinity-purified monospecific human anti-Ro60 
and anti-La antibodies were used.  One of the prerequisites 
for the use of these antibodies is cross-reactivity of the anti- 
bodies with their X.  /aev/s homologues. To study this, im- 
munoprecipitations with a radiolabeled X. laevis oocyte ex- 
tract  were  performed.  Precipitation  with  monospecific 
anti-La antibodies showed, that these antibodies recognized 
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from an 35S-labeled  X. laevis oocyte extract were immunoprecipi- 
tawxl using antibodies with various specificities and analyzed by 
SDS-PAGE. (Lane 1 ) Protein molecular weight markers. (Lane 2) 
Mixture of in vitro translated recombinant human La and Ro60 
(rRo/La). (Lane 3) Anti-La precipitation (a-La).  (Lane 4) Anti- 
Ro60 precipitation (c~-Ro60). (Lane 5) Anti-Sm precipitation (ct- 
Sm). (Lane 6) Normal human serum (NHS) precipitation.  (b) In 
vitro transcribed hY1 RNA and U1 RNA were co-injected into oo- 
cyte nuclei and after 18 h RNA from total oocytes (T), cytoplasmic 
(C),  and nuclear (N) fractions were extracted and analyzed by 
polyacrylamide gel electrophoresis (lanes 1-3). Cytoplasmic and 
nuclear fractions were used to perform immunopreeipitations with 
anti-La (lanes 4 and 5), anti-Ro60 (lanes 6 and 7), anti-Sm (lanes 
8 and 9), and normal human serum (lanes 10 and 11 ). C and N cor- 
respond to the cytoplasmic and nuclear fraction, respectively. 
at least one of the two X.  laevis La variants, which are not 
separated by SDS-PAGE (Fig.  3 a,  lane 3).  Precipitations 
with monospecific anti-Ro60 antibodies revealed that these 
antibodies were reactive with the X. laevis Ro60 homologue 
(Fig. 3 a, lane 4). When monospecific anti-Ro52 antibodies 
were  used  for  similar  immunoprecipitations  no  specific 
precipitation of a X.  laevis polypeptide was observed (data 
not shown). This is in agreement with previous results indi- 
cating that immunoreactive Ro52 could only be detected in 
primate cells (Slobbe et al.,  1991). As a control for the im- 
munoprecipitations normal human serum and a polyclonal 
serum containing antibodies to the Sm proteins, which are 
associated with U snRNPs and are present in X.  /aev/s oo- 
cytes (ZeUer et al.,  1983), were used (Fig. 3 a, lanes 6 and 
5, respectively). 
Using the monospecific affinity-purified anti-La and anti- 
Ro60 antibody preparations the association of X.  /aev/s La 
and Ro60 with hY1 RNA was investigated. When hY1 RNA 
and U1 RNA were co-injected into the nucleus of oocytes the 
expected distribution after an overnight incubation was ob- 
tained (Fig. 3 b, lanes 1-3). Cytoplasmic as well as nuclear 
extracts of these oocytes were used for immunoprecipita- 
tions.  Anti-Ro60 antibodies efficiently precipitated labeled 
bY1 RNA from the cytoplasmic extract, while anti-La anti- 
bodies resulted in signals that were not or hardly above back- 
ground (Fig.  3 b,  lanes 4-7).  Control antibodies from the 
anti-Sm or from a normal human serum did not precipitate 
hY1 RNA (Fig. 3 b, lanes 8-11 ). U1 RNA was, as expected, 
specifically precipitated by the  anti-Sm  antibodies,  espe- 
cially from the nuclear extract, in accordance with the nu- 
clear accumulation (Fig. 3 b, lanes 8 and 9). The specificity 
of the immunoprecipitation was  further confirmed by the 
lack of precipitation by normal human serum.  From these 
results  we  conclude  that  in  vitro  transcribed  hY1  RNA, 
which accumulates in the cytoplasm, is associated with the 
X. laevis Ro60 protein but apparently not or hardly with the 
X.  laevis La protein. 
The weak precipitation of hY1 RNA with anti-La antibod- 
ies as compared with anti-Ro60 antibodies was rather unex- 
pected, since several studies performed in mammalian cells 
indicate that in such cells most, if not all hY RNA molecules 
are associated with La (Boire and Craft,  1990; Peek et al., 
1993).  A possible explanation for this phenomenon is that 
this affinity-purified anti-La antibody is poorly recognizing 
and precipitating the X.  laevis La protein when associated 
with bY1 RNA. Differences in efficiency of precipitation of 
X. laevis La RNPs by various antibodies raised against hu- 
man  La have been  reported before (Terns  et  al.,  1992). 
Therefore, several monospecific anti-La sera were compared 
in  immunoprecipitating  capacity  of X.  /aev/s  La  from  a 
[35S]methionine-labeled oocyte extract.  The  monospecific 
anti-La  serum  used  in  the  experiments  described  above 
precipitated  both  human  and  X.  /aev/s  La  with  a  high 
efficiency (data  not  shown).  Furthermore,  this  antibody 
precipitated 32p-labeled  hY1  RNA  incubated in  an oocyte 
extract at least as efficiently as antibodies from other sera. 
In fact, hY1 RNA precipitation with the monospecific anti- 
Ro60 serum used in the experiment depicted in Fig. 3 b was 
less efficient than precipitation with the monospecific anti- 
La serum (data not shown). In conclusion, the weak precipi- 
tation of hY1 RNA from the oocyte cytoplasm by anti-La an- 
tibodies  does  not  seem  to  be  caused  by  the  quality  or 
specificity of the antibody used. 
To  shed  more  light  on  this  aspect  and  to  investigate 
whether the association of the X. laevis La and Ro60 proteins 
with hY1 RNA takes place in the cytoplasm or the nucleus, 
the following experiment was performed, hY1 RNA and U1 
RNA were co-injected into the nucleus of oocytes and, after 
4 and 18 h of incubation, nuclear and cytoplasmic fractions 
were prepared.  In  parallel,  extracts  were prepared  from 
similarly injected oocytes that were incubated for 18 h  at 
0°C. At the latter temperature, hY1 RNA and U1 RNA are 
not transported to the cytoplasm (Fig. 4 a, lanes 8-10). As 
observed before, after 4-h incubation at room temperature 
part of the hY1 and U1  RNAs had been transported to the 
cytoplasm (Fig. 4 a, lanes 2-4).  18 h  after injection most 
of the hY1 RNA was present in the cytoplasm while most of 
the U1  RNA had returned to the nucleus (Fig.  4  a,  lanes 
5-7).  Immunoprecipitations with  various  antibodies  were 
performed on the different cytoplasmic and  nuclear frac- 
tions. The precipitations with anti-La antibodies clearly in- 
dicate, that in the nucleus La efficiently associates with hY1 
RNA and that the La-hY1 RNA complex was found almost 
exclusively in the nucleus (Fig. 4 b, lane 2).  This is espe- 
cially evident after an incubation for 18 h at 0°C (Fig. 4 b, 
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cytes. (a) In vitro transcribed hYl RNA and U1  RNA were co- 
injected into the oocyte nucleus and incubated at room temperature 
(lanes 2-7) or 0°C (lanes 8-10). After 4 h (lanes 2-4) and 18 h 
(lanes 5-10) RNA from total oocytes (T), cytoplasmic (C), and nu- 
clear (N) fractions were extracted and analyzed on gel. (Lane 1 ) 
RNA extracted from oocytes immediately after injection (t =  0). 
The RNA in each lane corresponds to the contents of 0.5 oocyte 
or oocyte compartment. (b) Injected RNAs as in a were immuno- 
precipitated from the cytoplasmic (C) and nuclear (N) fractions 
with anti-La (lanes 1-6), anti-Ro60 (lanes 7-12), anti-Sm (lanes 
13-18), and normal human serum (lanes 19--24) and then analyzed 
by polyacrylamide gel electrophoresis. Material from three oocytes 
(or oocyte compartments) was used for each immunoprecipitation. 
Subscripts indicate the incubation times and superscripts refer to 
the incubation temperature before preparation of the extracts (no 
superscript corresponds to incubation at room temperature). 
lane 6). In the cytoplasmic fractions no or hardly any La-hY1 
RNA complex could be observed (Fig. 4 b, lanes 1, 3, and 
5). These results suggest that in X. laevis oocytes the associ- 
ation with La is  lost during transport of bY1  RNA to the 
cytoplasm. The latter observations are in agreement with the 
weak immunoprecipitation signals observed before (Fig.  3 
b). Similar precipitations with anti-Ro60 antibodies showed 
that hY1 RNA in the cytoplasm is associated with Ro60 while 
Ro60-hY1 RNA complexes in the nucleus are not detectable 
after incubations at room temperature (Fig. 4 b, lanes 7-10). 
In contrast, hY1 RNA in the nucleus is precipitable with anti- 
Ro60 antibodies when the oocytes are incubated at 0°C (Fig. 
4 b, lane 12), suggesting that the binding ofX. laevis Ro60 
to hY1 RNA takes place in the nucleus, followed by rapid ex- 
port  to  the  cytoplasm.  Control  precipitations  were  per- 
formed with anti-Sm antibodies and normal human serum. 
It appears that only U1  RNA molecules, that have passed 
through or are in the cytoplasm,  are immunoprecipitable 
with anti-Sm antibodies (Fig. 4  b,  lanes 13-17).  U1  RNA 
that did not leave the nucleus during the 0°C incubation and 
for that reason is not complexed with Sm proteins (Nigg et 
al.,  1991) could not be precipitated by anti-Sm antibodies, 
as expected (Fig. 4  b,  lane 18). 
Discussion 
The intracellular localization of Ro RNPs has been studied 
by several groups primarily using the immunofluorescence 
technique. The results of these studies were not very conclu- 
sive. In a recent study (Peek et al., 1993) it became clear that 
the localization as determined by immunofluorescence criti- 
cally depends on the cell fixation method. The contradicting 
results  obtained  with  the  immunofluorescence technique 
might be explained in part by leakage of intracellular compo- 
nents during fixation or by masking of epitopes due to fixa- 
tion. Recently, cell enucleation studies have shed more light 
on the intracellular localization of Ro RNPs (O'Brien et al., 
1993; Peek et al., 1993). In order to verify and extend these 
data a  second approach was chosen: injection of Ro RNP 
components into X.  laevis oocytes. This approach has also 
successfully been employed  to elucidate the intracellular dis- 
tribution and transport of different U snRNPs and their pro- 
teins (reviewed in Nigg et al.,  1991).  While this work was 
in progress Ro RNPs were identified and characterized in X. 
laevis (O'Brien et al., 1993), which allowed us to use the oo- 
cytes as a bona fide system to study the intracellular distribu- 
tion and transport of Ro RNP components. Four Y RNAs, 
corresponding to Y3, Y4, Y5, and an RNA not related to one 
of the human Y RNAs,  designated xYa RNA, as well as a 
60-kD Ro protein were characterized in X.  /aev/s. 
Ro RNP Proteins Are Actively Transported to 
the Nucleus 
When injected into the cytoplasm, the recombinant human 
La protein accumulates in the oocyte nucleus. The primarily 
nuclear localization is in agreement with the results obtained 
with immunofluorescence (Hendrick et al., 1981), cell frac- 
tionation (Habets et al., 1983) and immunoelectron micros- 
copy (Carmo-Fonseca et al.,  1989).  The observation that 
Ro60 and Ro52 are also actively transported to the nucleus, 
although less efficiently, is in agreement with data obtained 
by cell enucleation of Jurkat and  3T3  cells  (Peek et al., 
1993).  After cell  enucleation  La,  Ro52,  and  Ro60  were 
found in both cytoplasm and  nucleus.  Minor quantitative 
differences obtained by different techniques as oocyte injec- 
tion and cell enucleation might be explained by the different 
cell types that were used in these studies and/or by differ- 
ences in the total amount of Ro or La protein per cell. Fur- 
thermore, one should realize that the binding to endogenous 
components, like Y RNAs,  may influence the intracellular 
distribution of the injected molecules. 
All three proteins are transported to the nucleus via an ac- 
tive transport mechanism. This probably implies that a nu- 
clear localization signal  (NLS) is  involved.  An NLS  is  a 
structural element that both is necessary and sufficient for 
transport of a protein to the nucleus. A nuclear protein will 
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sport while associated with another protein containing an 
NLS (Silver, 1991; Garcia-Bustos et al.,  1991). A sequence 
element matching the bipartite NLS (Dingwall et al., 1991), 
which is found in the majority of nuclear proteins, is present 
in La but not in Ro60 or Ro52. At present, studies are being 
performed to determine which sequences in La, Ro60, and 
Ro52 are involved in nuclear import of these proteins. 
Y RNAs Are Located in the Cytoplasm 
In contrast to the Ro RNP-specific proteins, hY RNAs were 
found to be located exclusively in the cytoplasm after an 
overnight incubation of injected oocytes. Upon injection hY 
RNAs  are  actively exported out  of the  nucleus  into  the 
cytoplasm. These results are in agreement with the data ob- 
tained with cell enucleation studies (O'Brien et al.,  1993; 
Peek et ai.,  1993) in which human and murine cells were 
used. In vivo transcribed hY3 RNA also accumulated in the 
cytoplasm, thereby justifying the use of in vitro transcribed 
RNAs.  In accordance with our results, the endogenous X. 
/aev/s xY RNAs were recently also shown to be exclusively 
localized in the oocyte cytoplasm (O'Brien et al.,  1993). It 
therefore seems unlikely that the use of a heterologous RNA 
might have influenced the results. 
The hY1 gene was transcribed very poorly in X./aev/s oo- 
cytes and produced several transcripts of approximately hY1 
RNA size.  A  possible explanation for the inefficient tran- 
scription of the hY1 gene is that the upstream sequence pres- 
ent in this genomic clone was relatively small (`ol00 bp, in- 
stead of,o400 bp in the case of  the hY3 gene). Probably some 
essential transcription regulatory sequence elements in the 
hY1 gene are lacking. 
Interaction of X. laevis La and Ro60 with hY1 RNA 
La is evolutionarily reasonably well conserved, as has been 
shown by Western blotting data (Hoch et al.,  1984; Slobbe 
et al., 1991b) and cDNA sequence comparisons (Chan et al., 
1989b; Scherly et al.,  1993; Topfer et al.,  1993; Semsei et 
al.,  1993). Two X.  /aev/s La cDNA variants have been de- 
scribed. Both encode polypeptides that are about 20-amino 
acids longer (427 and 428 amino acids,  respectively) than 
their human counterpart (Scherly et al.,  1993). Monospe- 
cific anti-La antibodies immunoprecipitated at least one of 
these X.  laevis La proteins which indeed had an apparent 
molecular weight somewhat higher than that of the human 
La protein. Like human La, X./aev/s La was able to associ- 
ate with hY1 RNA. The evolutionary conservation of Ro60 
is also evident: 60-kD proteins from various species react on 
Western blots with antibodies raised against human Ro60 
(Mamula  et  al.,  1989a;  Slobbe  et  al.,  1991b).  By  im- 
munofluorescence the existence of the Ro/SS-A antigen in 
frogs has been demonstrated (Xia et al., 1987). A cDNA en- 
coding a  60-kD  Ro protein  sharing  78%  amino  acid  se- 
quence identity with human Ro60 has recently been isolated 
from a X.  /aev/s cDNA library (O~Brien et al.,  1993). Our 
immunoprecipitation experiments showed that X.  /aev/s in- 
deed contains a 60-kD protein which is reactive with anti- 
Ro60 antibodies and is able to interact with hY1 RNA (Fig. 
3 a, lane 4 and b, lane 6). 
Analyses of the association ofX. /aev/s La with hY1 RNA 
strongly suggest that during or shortly after export from the 
nucleus La dissociates from hY1 RNA in oocytes. A similar 
phenomenon has been observed with the  transport of 5S 
rRNA from nucleus to cytoplasm in X./aev/s oocytes (Gud- 
dat et al.,  1990). The loss of association with La might be 
related to the fact that pre-5S rRNA loses its 3' U-stretch 
upon processing. At the moment it is not clear whether the 
human Y RNAs in X./aev/s oocytes are also subject to pro- 
cessing events at their 3'-end. The apparent dissociation of 
La from hY1 RNA in X. /aev/s oocytes is, however, in con- 
tradiction to the results obtained by enucleation (Peek et ai., 
1993) and fractionation (Boire and Craft,  1990) of human 
cells because Y  RNAs were found to be stably associated 
with the La protein in these cells. Future studies will show 
whether dissociation of La from Y RNAs is dependent on the 
type of cell studied. 
In addition to La, X.  laevis Ro60 was found to associate 
with hY1 RNA.  The low level of association of Ro60 with 
nuclear hY1 RNA as detected at 4 h after injection suggests 
that the association with Ro60 might be the rate limiting step 
in nuclear export of hY1 RNA.  An alternative explanation 
would be that the Ro60-hY1 RNA association in the nucleus 
is very inefficient and mostly takes place after export of bY1 
RNA to the cytoplasm. Indeed, the Ro60-hY1 RNA associa- 
tion in the nucleus at 0°C incubation appears to be rather 
inefficient (Fig. 4 B, lane 12), which may, however, also be 
related to the smaller amount of Ro60 in the oocyte nucleus 
in comparison with the amount of La. Alternatively, the as- 
sociation of Ro60 with hY1  RNA in the nucleus might be 
temperature dependent. Preliminary results of experiments, 
in which we injected a hY1 RNA mutant that was unable to 
associate with Ro60, however, strongly suggest that Ro60 
binding in the nucleus is required for efficient export of hY1 
RNA to the cytoplasm (unpublished observations). 
The results presented in Fig. 4 might suggest that the bind- 
ing of endogenous Ro60 and La to hY1 RNA injected into 
oocytes is mutually exclusive. Although we can not com- 
pletely exclude this possibility for the X./aev/s proteins, sev- 
eral data obtained with the human and mouse proteins, how- 
ever, indicate that both proteins can simultaneously bind to 
one hY RNA molecule (Mamula et al.,  1989b; Boire et al., 
1990; Peek et al.,  1993). 
The combination of the present results and the results ob- 
tained by enucleation of  human and murine cells (Peek et al., 
1993) leads to the following model for Ro RNP synthesis and 
assembly. Ro60 and La, after translation in the cytoplasm, 
are actively transported to the nucleus. In the nuclear com- 
partment they associate with Y RNAs shortly after or even 
during transcription. Once such complexes have been formed, 
they are rapidly and actively exported out of the nucleus to 
the cytoplasm where they will  fulfill their function(s).  It 
should be noted that our results do not exclude the possibility 
that other, yet unidentified factors are also involved in the 
transport process. 
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